Head And Neck Cancer (HNC) Market Poised for 8% Growth, Set to Hit $15.55 Billion by 2029

How Is the Head And Neck Cancer (HNC) Market Projected to Grow, and What Is Its Market Size?
Over the recent years, the market size for head and neck cancer (HNC) has seen robust growth. The market is projected to rise from $2.00 billion in 2024 to $2.17 billion in 2025, marking a compound annual growth rate (CAGR) of 8.2%. The factors contributing to the notable growth during the historical period includes an increasing prevalence of HPV-related cancers, a surge in smoking and alcohol consumption, heightened investment in cancer research, improved awareness and early detection, as well as an expanding aged population.

The market for head and neck cancer (HNC) is projected to witness robust expansion in the coming years, growing to $2.93 billion in 2029 with a compound annual growth rate (CAGR) of 7.8%. This surge in growth during the forecast period can be credited to factors such as the development of healthcare infrastructure, increasing patient numbers, an aging population, higher healthcare spending, and a high prevalence of tobacco and alcohol usage. The market forecast period is also expected to be shaped by significant trends like advancements in immunotherapy, targeted treatments, technological enhancements, the incorporation of artificial intelligence (AI), and precision medicine.

What Are the Key Drivers Behind the Growth of the Head And Neck Cancer (HNC) Market?
The surge in cigarette smoking rates is predicted to stimulate the expansion of the head and neck cancer (HNC) market. The act of cigarette smoking, characterized by inhalation and exhalation of smoke from lit tobacco contained in cigarettes, is often linked with health hazards and dependency. Factors such as stress, societal influences, assertive advertising, and the availability of tobacco goods frequently spur the growing incidence of cigarette smoking. Drugs for head and neck cancer serve to counteract the detrimental effects of cigarette consumption by focusing on molecular alterations caused by smoking and treating cancers related to tobacco use. They also underline the necessity of limiting exposure to carcinogens associated with smoking for improved treatment results. For example, a study by the European Respiratory Society (ERS), a non-profit organization based in Switzerland, showed a marked upturn in cigarette smoking rates among young individuals in October 2024, with 22.5% of participants reported as smokers in 2022 rising to 40.1% in 2024. Hence, the escalating prevalence of cigarette smoking is fueling the growth of the head and neck cancer (HNC) market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20825&type=smp

Who Are the Major Industry Players Fueling Head And Neck Cancer (HNC) Market Expansion?
Major companies operating in the head and neck cancer (HNC) market are Pfizer Inc., Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer Healthcare AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Koninklijke Philips N.V., Boehringer Ingelheim, Fresenius Kabi AG, Incyte Corporation, Exelixis Inc., Astellas Pharma Inc., Rakuten Medical Inc., Merus N.V.

Which Key Developments Are Influencing the Head And Neck Cancer (HNC) Market?
Key businesses operating in the head and neck cancer (HNC) market are orienting their efforts towards creating innovative solutions like immuno-oncology drugs. Their main focus is on enhancing the efficacy of treatments, advancing patient survival rates, and catering to the unaddressed medical needs in the management of sophisticated and late-stage cancers. Immuno-oncology medications are treatments that utilize the individual's immune system to identify and combat cancerous cells. Therapies like checkpoint inhibitors, CAR-T cell treatments, and cancer vaccines fall under this category. For instance, toripalimab, an immuno-oncology medication designed for adults suffering from an unusual type of head and neck cancer starting at the nasopharynx (upper throat region), was launched by Dr. Reddy's Laboratories, an Indian pharmaceutical firm, in November 2024. The drug is aimed at treating recurrent or metastatic nasopharyngeal carcinoma, and it will be sold under the brand name Zytorvi. When combined with conventional chemotherapy (gemcitabine and cisplatin), the drug has shown a 48% reduction in the risk of cancer progression or death.

How Is the Segmentation of the Head And Neck Cancer (HNC) Market Defined?
The head and neck cancer (HNC) market covered in this report is segmented -

1) By Type: Laryngeal Cancer, Pharyngeal Cancer, Salivary Gland Cancer, Lip And Oral Cavity Cancer, Nasopharyngeal Cancer, Other Types
2) By Treatment: Chemotherapy, Surgery, Radiation Therapy, Targeted Therapy, Other Treatments
3) By Diagnosis: Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, Endoscopy
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, E-commerce
5) By End User: Hospital, Specialty Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Laryngeal Cancer: Supraglottic Laryngeal Cancer, Glottic Laryngeal Cancer, Subglottic Laryngeal Cancer
2) By Pharyngeal Cancer: Oropharyngeal Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer
3) By Salivary Gland Cancer: Parotid Gland Cancer, Sublingual Gland Cancer, Submandibular Gland Cancer, Minor Salivary Gland Cancer
4) By Lip And Oral Cavity Cancer: Lip Cancer, Buccal Mucosa Cancer, Tongue Cancer, Gingival Cancer, Palate Cancer
5) By Nasopharyngeal Cancer: Early-Stage Nasopharyngeal Cancer, Advanced-Stage Nasopharyngeal Cancer
6) By Other Types: Thyroid Cancer, Esophageal Cancer, Sinonasal Cancer

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-hnc-global-market-report

What Is the Leading Region in the Head And Neck Cancer (HNC) Market?
North America was the largest region in the head and neck cancer (HNC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer (HNC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Head And Neck Cancer (HNC) Global Market Report?

- Market Size Analysis: Analyze the head and neck cancer (hnc) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the head and neck cancer (hnc) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall head and neck cancer (hnc) market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the head and neck cancer (hnc) market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20825

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.